These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2842633)

  • 1. Purification of cGMP-binding protein phosphodiesterase from rat lung.
    Francis SH; Corbin JD
    Methods Enzymol; 1988; 159():722-9. PubMed ID: 2842633
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of rod outer segment GTP-binding protein subunits and cGMP phosphodiesterase by single-step column chromatography.
    Yamazaki A; Tatsumi M; Bitensky MW
    Methods Enzymol; 1988; 159():702-10. PubMed ID: 2842631
    [No Abstract]   [Full Text] [Related]  

  • 3. Photoaffinity labeling of high-affinity cGMP-specific noncatalytic binding sites on cGMP phosphodiesterase of rod outer segments.
    Yamazaki A; Bitensky MW; Casnellie JE
    Methods Enzymol; 1988; 159():730-6. PubMed ID: 2842634
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.
    Thomas MK; Francis SH; Corbin JD
    J Biol Chem; 1990 Sep; 265(25):14964-70. PubMed ID: 1697584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of bovine retinal cGMP phosphodiesterase.
    Tar A; Ting TD; Ho YK
    Methods Enzymol; 1994; 238():3-12. PubMed ID: 7799796
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and comparison of bovine heart cGMP-inhibited and cGMP-stimulated phosphodiesterases.
    Harrison SA; Beier N; Martins TJ; Beavo JA
    Methods Enzymol; 1988; 159():685-702. PubMed ID: 2842630
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet cGMP-binding phosphodiesterase.
    Hamet P; Tremblay J
    Methods Enzymol; 1988; 159():710-22. PubMed ID: 2842632
    [No Abstract]   [Full Text] [Related]  

  • 8. Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Changes in molecular size assessed by gel filtration and electrophoresis.
    Kincaid RL; Manganiello VC; Vaughan M
    J Biol Chem; 1981 Nov; 256(21):11345-50. PubMed ID: 6270149
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of cellular retinoic acid-binding proteins types I and II from neonatal rat pups.
    Bailey JS; Siu CH
    Methods Enzymol; 1990; 189():356-63. PubMed ID: 1963466
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectors of rat lung cGMP binding protein-phosphodiesterase.
    Francis SH
    Curr Top Cell Regul; 1985; 26():247-62. PubMed ID: 2416513
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of soluble rat cardiac phosphodiesterases by high performance liquid chromatography.
    Bode DC; Kanter JR; Brunton LL
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):235-40. PubMed ID: 2856111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for the purification of the regulator of cyclic nucleotide phosphodiesterase from rat liver utilizing its calcium-binding ability.
    MacManus JP
    Anal Biochem; 1979 Jul; 96(2):407-10. PubMed ID: 224729
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of rat liver folate-binding protein: cytosol I.
    Cook RJ; Wagner C
    Methods Enzymol; 1986; 122():251-5. PubMed ID: 3517563
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
    Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
    Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
    Kincaid RL; Manganiello VC
    Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue.
    Miot F; Van Haastert PJ; Erneux C
    Eur J Biochem; 1985 May; 149(1):59-65. PubMed ID: 2581780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two forms of Ca2+-dependent cyclic 3':5'-nucleotide phosphodiesterase from human aorta and effect of free fatty acids.
    Hidaka H; Yamaki T; Yamabe H
    Arch Biochem Biophys; 1978 Apr; 187(2):315-21. PubMed ID: 208464
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of the cyclic GMP phosphodiesterase from rat lung. Inhibition by unsaturated fatty acids.
    Coquil JF
    Biochim Biophys Acta; 1983 Mar; 743(3):359-69. PubMed ID: 6299362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.
    Strewler GJ; Danello MA; Manganiello VC; Vaughan M
    Biochem J; 1983 Aug; 213(2):379-86. PubMed ID: 6311163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific cyclic GMP phosphodiesterase of the retinal interphotoreceptor matrix.
    Barbehenn E; Wiggert B; Redmond T; Chader G
    Prog Clin Biol Res; 1985; 190():129-40. PubMed ID: 2996020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.